(Q33967082)

30 July 2017

Interruption of HBV intrauterine transmission: a clinical study (English)

1 reference

30 July 2017

Xiao-Mao Li

1

1 reference

30 July 2017

Yue-Bo Yang

2

1 reference

30 July 2017

Hong-Ying Hou

3

1 reference

30 July 2017

Zhong-Jie Shi

4

1 reference

30 July 2017

Hui-Min Shen

5

1 reference

30 July 2017

Ben-Qi Teng

6

1 reference

30 July 2017

Ai-Min Li

7

1 reference

30 July 2017

Min-Feng Shi

8

1 reference

30 July 2017

Ling Zou

9

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

World Journal of Gastroenterology

30 July 2017

1 reference

30 July 2017

9

1 reference

30 July 2017

7

1 reference

30 July 2017

1501-1503

1 reference

Efficacy of lamivudine in HBeAg-negative chronic hepatitis B.

30 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615491

Relationship between HBV viremia level of pregnant women and intrauterine infection:neated PCR for detection of HBV DNA

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615491

Current management strategies for hepatitis B in the elderly

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615491

Prevention of intrauterine infection by hepatitis B virus with hepatitis B immune globulin: efficacy and mechanism

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615491

Prenatal AZT or 3TC and mouse development of locomotor activity and hot-plate responding upon administration of the GABA(A) receptor agonist muscimol.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615491

Viral hepatitis and pregnancy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615491

Current therapeutic trends in therapy for chronic viral hepatitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615491

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615491

Perinatal transmission of hepatitis B virus in high-incidence countries

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615491

Significance of isolated hepatitis B core antibodies detected by enzyme immunoassay in a high risk population

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615491

Mother-child transmission of hepatitis B virus. State of the problem and prevention

5 July 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V9.I7.1501

Perinatal transmission of hepatitis B virus and its prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V9.I7.1501

Role of placental tissues in the intrauterine transmission of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V9.I7.1501

Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V9.I7.1501

Clinical pharmacokinetics of lamivudine

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V9.I7.1501

Prenatal exposure to anti-HIV drugs. long-term neurobehavioral effects of lamivudine (3TC) in CD-1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V9.I7.1501

Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V9.I7.1501

Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V9.I7.1501

Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: a placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V9.I7.1501

Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V9.I7.1501

Hepatitis B virus DNA in peripheral blood leukocytes. A comparison between hepatocellular carcinoma and other hepatitis B virus-related chronic liver diseases

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4615491

Hepatitis B surface antigenemia at birth: A long-term follow-up study

29 October 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V9.I7.1501

Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates

21 January 2018

1 reference

12 December 2020

A case of HBs antigen negative fulminant hepatitis with IgM antibody to hepatitis B core antigen persisting more than seven years

1 reference

12 December 2020

Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission--Thailand, 1996-1998

1 reference

12 December 2020

Results of long-term follow-up of HIV-infected patients treated with lamivudine monotherapy, followed by a combination of lamivudine and zidovudine

1 reference

12 December 2020

Infection of the fetus with hepatitis B e antigen via the placenta

1 reference

12 December 2020

A preliminary study on interruption of HBV transmission in uterus

1 reference

12 December 2020

A preliminary trial of lamivudine for chronic hepatitis B infection

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V9.I7.1501

1 reference

30 July 2017

1 reference

30 July 2017

1 reference